Replies to post #447859 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

In principle yes there could be a class period from the "met all endpoints" statement with 8-K filing and until a clear disclosure that all endpoints were not met, within which some investors would be damaged.

However, for that case to be successfully made the end of class period date (determined by the last disclosure) would have to be associated with a statistically significant drop in the price of $AVXL. If the disclosure that all endpoints were not met per protocol comes at a time when the market is expecting approval from the totality of data or approval is announced, there would be no end of class period price drop and no case.